Daiichi Ranbaxy is planning to launch a generic version of tamsulosin to treat enlarged prostate in US by March 2010.
A drug to treat triple negative braest cancer BSI-201 may get a faster review in US.
A needle-free vaccine against traveller's diarhoea may be in the offing.
BIOMAb EGFR, an anti-cancer drug developed by India's Biocon Ltd, will be studied for use in cervical cancer.
Pharma MNCs operating in India are drawing up aggressive strategies to tap into the rural markets where India's two-third of the population live.